Welcome to our dedicated page for Silk Road Medical news (Ticker: SILK), a resource for investors and traders seeking the latest updates and insights on Silk Road Medical stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Silk Road Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Silk Road Medical's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Silk Road Medical (Nasdaq: SILK), a medical device company dedicated to stroke risk reduction, will participate in the BofA Securities 2023 Healthcare Conference on May 10, 2023, at 4:20 p.m. PT. Interested individuals can access a live and archived webcast via the company’s website.
The company is known for its innovative approach to treating carotid artery disease through a procedure called TransCarotid Artery Revascularization (TCAR), which combines surgical neuroprotection principles with minimally invasive techniques.
For further inquiries, reach the Investor Contact at investors@silkroadmed.com.
Silk Road Medical, Inc. (Nasdaq: SILK) will release its first quarter 2023 financial results on May 9, 2023, after market close, followed by an audio webcast at 1:30 p.m. PT. The company, based in Sunnyvale, California, specializes in reducing stroke risk through its innovative TransCarotid Artery Revascularization (TCAR) procedure. This method merges surgical neuroprotection with minimally invasive techniques to address carotid artery blockages.
Interested parties can register for the conference call online and join the live or replay webcast to gain insights into the company’s financial performance and future outlook.
FAQ
What is the current stock price of Silk Road Medical (SILK)?
What is the market cap of Silk Road Medical (SILK)?
